English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma

Andrej, B., Lenka, B., Buchler, L., Stolze, S., Sobh, A., Kraus, M., et al. (2021). Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma. Clinical Lymphoma Myeloma and Leukemia, 21, S88-S89.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Andrej, B.1, Author
Lenka, B.1, Author
Buchler, L.1, Author
Stolze, S.2, Author              
Sobh, A.1, Author
Kraus, M.1, Author
Nakagami, H.2, Author              
Driessen, C.1, Author
Affiliations:
1external, ou_persistent22              
2Mass Spectrometry, MPI for Plant Breeding Research, Max Planck Society, ou_1113575              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 20212021
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Clinical Lymphoma Myeloma and Leukemia
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA : CIG MEDIA GROUP, LP
Pages: - Volume / Issue: 21 Sequence Number: - Start / End Page: S88 - S89 Identifier: -